2-((3S,5R)-3,5-dimethylpiperazin-1-yl)benzo[4,5]imidazo[1,2-a][1,8]naphthyridine-6-carbonitrile 基本信息
MSDS 用途与合成方法 2-((3S,5R)-3,5-dimethylpiperazin-1-yl)benzo[4,5]imidazo[1,2-a][1,8]naphthyridine-6-carbonitrile价格(试剂级) 上下游产品信息
| 中文名称 | 2-((3S,5R)-3,5-dimethylpiperazin-1-yl)benzo[4,5]imidazo[1,2-a][1,8]naphthyridine-6-carbonitrile |
|---|---|
| 中文同义词 | 化合物COMPOUND 3A;REL-2-((3R,5S)-3,5-二甲基哌嗪-1-基)苯并[4,5]咪唑并[1,2-A][1,8]萘啶-6-甲腈;化合物3A |
| 英文名称 | 2-((3S,5R)-3,5-dimethylpiperazin-1-yl)benzo[4,5]imidazo[1,2-a][1,8]naphthyridine-6-carbonitrile |
| 英文同义词 | 2-((3S,5R)-3,5-dimethylpiperazin-1-yl)benzo[4,5]imidazo[1,2-a][1,8]naphthyridine-6-carbonitrile;POL1 inhibitor;CAS1822358-25-7;2-[(3R,5S)-3,5-dimethylpiperazin-1-yl]benzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;DC10539;Benzimidazo[1,2-a][1,8]naphthyridine-6-carbonitrile, 2-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-, rel-;POL1-IN-1;POL1 IN 1,POL-1-IN-1,proliferation,inhibit,cancer,Inhibitor,cell,transcription,DNA/RNA Synthesis,POL1IN1 |
| CAS号 | 1822358-25-7 |
| 分子式 | C21H20N6 |
| 分子量 | 356.42 |
| EINECS号 | |
| 相关类别 | 标准品 |
| Mol文件 | 1822358-25-7.mol |
| 结构式 | ![2-((3S,5R)-3,5-dimethylpiperazin-1-yl)benzo[4,5]imidazo[1,2-a][1,8]naphthyridine-6-carbonitrile 结构式](CAS/20180601/GIF/1822358-25-7.gif) |
2-((3S,5R)-3,5-dimethylpiperazin-1-yl)benzo[4,5]imidazo[1,2-a][1,8]naphthyridine-6-carbonitrile 性质
安全信息
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2023/01/06 | S0327 | 2-((3S,5R)-3,5-dimethylpiperazin-1-yl)benzo[4,5]imidazo[1,2-a][1,8]naphthyridine-6-carbonitrile Compound 3A | 1822358-25-7 | 5mg | 2841.93元 |
| 2023/01/06 | S0327 | 2-((3S,5R)-3,5-dimethylpiperazin-1-yl)benzo[4,5]imidazo[1,2-a][1,8]naphthyridine-6-carbonitrile Compound 3A | 1822358-25-7 | 25mg | 8591.31元 |